Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mallinckrodt Plc (NONE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mallinckrodt Plc. Table 2 shows the detailed insider transactions. This company's CIK number is 1567892.
Total stock buying since 2014: $72,195,813.
Total stock sales since 2014: $35,687,798.
Total stock option exercises since 2014: $8,044,930.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 86,700 | $7,562,250 | 0 | $0 | 36,108 | $0 |
| 2024 | 1,173,300 | $59,082,100 | 0 | $0 | 0 | $0 |
| 2023 | 39,000 | $330,406 | 0 | $0 | 0 | $0 |
| 2022 | 0 | $0 | 34,065 | $3,985 | 0 | $0 |
| 2021 | 0 | $0 | 65,859 | $25,453 | 0 | $0 |
| 2020 | 0 | $0 | 458,264 | $72,373 | 0 | $0 |
| 2019 | 9,400 | $105,887 | 0 | $0 | 0 | $0 |
| 2018 | 4,000 | $66,794 | 312,928 | $4,144,731 | 0 | $0 |
| 2017 | 86,273 | $2,337,295 | 0 | $0 | 2,000 | $62,460 |
| 2016 | 12,053 | $749,779 | 0 | $0 | 0 | $0 |
| 2015 | 24,141 | $1,942,051 | 265,441 | $31,441,256 | 274,321 | $7,982,470 |
| 2014 | 260 | $19,251 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 86,700 | $7,562,250 | 0 | $0 | 0 | $0 |
| 2025-07 | 0 | $0 | 0 | $0 | 36,108 | $0 |
| 2024-07 | 13,300 | $724,850 | 0 | $0 | 0 | $0 |
| 2024-06 | 275,000 | $14,506,250 | 0 | $0 | 0 | $0 |
| 2024-05 | 640,000 | $34,493,750 | 0 | $0 | 0 | $0 |
| 2024-02 | 245,000 | $9,357,250 | 0 | $0 | 0 | $0 |
| 2023-03 | 39,000 | $330,406 | 0 | $0 | 0 | $0 |
| 2022-03 | 0 | $0 | 34,065 | $3,985 | 0 | $0 |
| 2021-08 | 0 | $0 | 7,180 | $1,873 | 0 | $0 |
| 2021-03 | 0 | $0 | 58,679 | $23,580 | 0 | $0 |
| 2020-12 | 0 | $0 | 94,685 | $25,957 | 0 | $0 |
| 2020-11 | 0 | $0 | 363,579 | $46,416 | 0 | $0 |
| 2019-06 | 5,400 | $48,384 | 0 | $0 | 0 | $0 |
| 2019-05 | 3,000 | $34,853 | 0 | $0 | 0 | $0 |
| 2019-03 | 1,000 | $22,650 | 0 | $0 | 0 | $0 |
| 2018-12 | 1,000 | $20,180 | 0 | $0 | 0 | $0 |
| 2018-05 | 3,000 | $46,614 | 312,928 | $4,144,731 | 0 | $0 |
| 2017-11 | 64,960 | $1,400,699 | 0 | $0 | 0 | $0 |
| 2017-08 | 1,280 | $50,725 | 0 | $0 | 0 | $0 |
| 2017-06 | 12,800 | $521,676 | 0 | $0 | 2,000 | $62,460 |
| 2017-05 | 1,968 | $90,911 | 0 | $0 | 0 | $0 |
| 2017-03 | 890 | $44,115 | 0 | $0 | 0 | $0 |
| 2017-02 | 4,375 | $229,169 | 0 | $0 | 0 | $0 |
| 2016-05 | 4,053 | $236,921 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-06 | Tananbaum Steven A. | Buy | 6,700 | 92.50 | 619,750 |
| 2025-08-04 | Tananbaum Steven A. | Buy | 30,000 | 87.25 | 2,617,500 |
| 2025-08-01 | Tananbaum Steven A. | Buy | 50,000 | 86.50 | 4,325,000 |
| 2025-07-31 | Hussain Abbas | Option Ex | 12,036 | .00 | 0 |
| 2025-07-31 | Stetson David J. | Option Ex | 12,036 | .00 | 0 |
| 2025-07-31 | Wheeler Wesley | Option Ex | 12,036 | .00 | 0 |
| 2024-07-08 | Tananbaum Steven A. | Buy | 13,300 | 54.50 | 724,850 |
| 2024-06-14 | Tananbaum Steven A. | Buy | 275,000 | 52.75 | 14,506,250 |
| 2024-05-24 | Tananbaum Steven A. | Buy | 165,000 | 50.00 | 8,250,000 |
| 2024-05-09 | Tananbaum Steven A. | Buy | 475,000 | 55.25 | 26,243,750 |
| 2024-02-15 | Tananbaum Steven A. | Buy | 225,000 | 38.25 | 8,606,250 |
| 2024-02-02 | Tananbaum Steven A. | Buy | 20,000 | 37.55 | 751,000 |
| 2023-03-15 | Sulat James R | Buy | 15,000 | 8.54 | 128,160 |
| 2023-03-14 | Bisaro Paul | Buy | 5,000 | 8.47 | 42,330 |
| 2023-03-14 | Sulat James R | Buy | 15,000 | 8.42 | 126,314 |
| 2023-03-13 | Welch Stephen Andrew (EVP & Head of Spec Generics) | Buy | 1,000 | 8.48 | 8,480 |
| 2023-03-13 | Olafsson Sigurdur O (President and CEO) | Buy | 3,000 | 8.37 | 25,122 |
| 2022-03-17 | Reed Joann A | Sale | 34,065 | .12 | 3,985 |
| 2021-08-05 | O'neill Hugh M. (EVP & Chief Comm & Ops Ofcr) | Sale | 2,100 | .26 | 537 |
| 2021-08-05 | Norton David Y (Director) | Sale | 5,080 | .26 | 1,336 |
| 2021-03-12 | Paya Carlos V | Sale | 16,614 | .40 | 6,712 |
| 2021-03-12 | Carroll J Martin | Sale | 42,065 | .40 | 16,868 |
| 2020-12-17 | Norton David Y | Sale | 5,080 | .40 | 2,052 |
| 2020-12-17 | Casey Mark J (EVP and Chief Legal Officer) | Sale | 15,291 | .45 | 6,880 |
| 2020-12-16 | Norton David Y | Sale | 21,807 | .43 | 9,464 |
| 2020-12-07 | Carlucci David R | Sale | 16,020 | .14 | 2,194 |
| 2020-12-04 | Carlucci David R | Sale | 31,087 | .14 | 4,476 |
| 2020-12-03 | Reasons Bryan M. (EVP & CFO) | Sale | 5,400 | .17 | 891 |
| 2020-11-16 | O'neill Hugh M. (EVP & Chief Comm & Ops Ofcr) | Sale | 750 | .13 | 94 |
| 2020-11-12 | Trudeau Mark (President and CEO) | Sale | 217,072 | .13 | 27,351 |
| 2020-11-12 | Russell Angus C. | Sale | 51,789 | .13 | 6,680 |
| 2020-11-11 | Watkins Ian J (EVP and Chief HR Officer) | Sale | 34,581 | .13 | 4,495 |
| 2020-11-06 | Whitaker Anne Clem | Sale | 21,087 | .13 | 2,741 |
| 2020-11-06 | Youngblood Dr Kneeland | Sale | 38,300 | .13 | 5,055 |
| 2019-06-07 | Reasons Bryan M. (EVP & CFO) | Buy | 5,400 | 8.96 | 48,384 |
| 2019-05-30 | Trudeau Mark (President and CEO) | Buy | 2,000 | 9.26 | 18,528 |
| 2019-05-09 | Trudeau Mark (President and CEO) | Buy | 1,000 | 16.32 | 16,325 |
| 2019-03-05 | Trudeau Mark (President and CEO) | Buy | 1,000 | 22.65 | 22,650 |
| 2018-12-10 | Trudeau Mark (President and CEO) | Buy | 1,000 | 20.18 | 20,180 |
| 2018-05-16 | Trudeau Mark (President and CEO) | Buy | 3,000 | 15.54 | 46,614 |
| 2018-05-09 | Deerfield Partners, L.p. | Sale | 312,928 | 13.24 | 4,144,731 |
| 2017-11-28 | Youngblood Dr Kneeland (Director) | Buy | 4,560 | 21.94 | 100,046 |
| 2017-11-14 | O'neill Hugh M. (Exec. VP & Pres, ARD) | Buy | 9,000 | 21.80 | 196,200 |
| 2017-11-14 | Watkins Ian J (Chief HR Officer) | Buy | 2,000 | 21.08 | 42,156 |
| 2017-11-13 | Romano Steven J. (Exec. VP & Chief Sci. Ofcr) | Buy | 2,000 | 21.96 | 43,920 |
| 2017-11-13 | Gulyas Diane H. (Director) | Buy | 1,500 | 21.30 | 31,950 |
| 2017-11-13 | Zaccagnino Joseph A (Director) | Buy | 5,000 | 21.30 | 106,500 |
| 2017-11-13 | Reed Joann A (Director) | Buy | 1,000 | 21.50 | 21,500 |
| 2017-11-13 | Booth Melvin D (Director) | Buy | 10,000 | 21.82 | 218,240 |
| 2017-11-10 | Trudeau Mark (President and CEO) | Buy | 5,000 | 22.28 | 111,400 |
| 2017-11-10 | Norton David Y (Director) | Buy | 2,000 | 22.02 | 44,030 |
| 2017-11-09 | Hicks Michael-bryant (General Counsel) | Buy | 7,900 | 20.80 | 164,312 |
| 2017-11-09 | Carroll J Martin (Director) | Buy | 5,000 | 20.42 | 102,095 |
| 2017-11-09 | Carlucci David R (Director) | Buy | 10,000 | 21.84 | 218,350 |
| 2017-08-30 | Fischer Meredith B (Chief Public Affairs Officer) | Buy | 1,280 | 39.63 | 50,725 |
| 2017-06-09 | Lloyd Ronald K. (Exec. VP & Pres, Hospital) | Buy | 5,000 | 41.26 | 206,320 |
| 2017-06-09 | Romano Steven J. (Exec. VP & Chief Sci. Ofcr) | Buy | 1,000 | 39.88 | 39,881 |
| 2017-06-09 | Schaefer Kathy A (Sr. VP & Corp. Controller) | Option Ex | 2,000 | 31.23 | 62,460 |
| 2017-06-09 | Trudeau Mark (President and CEO) | Buy | 1,000 | 40.17 | 40,174 |
| 2017-06-09 | Lannum Coleman N Iii (Sr. VP Investor Strategy & IRO) | Buy | 2,950 | 39.83 | 117,495 |
| 2017-06-08 | O'neill Hugh M. (Exec. VP & Pres, ARD) | Buy | 1,000 | 40.24 | 40,237 |
| 2017-06-05 | Lannum Coleman N Iii (Sr. VP Investor Strategy & IRO) | Buy | 500 | 39.33 | 19,665 |
| 2017-06-02 | Lannum Coleman N Iii (Sr. VP Investor Strategy & IRO) | Buy | 1,350 | 42.89 | 57,904 |
| 2017-05-12 | Lannum Coleman N Iii (Sr. VP Investor Strategy & IRO) | Buy | 1,968 | 46.20 | 90,911 |
| 2017-03-10 | Harbaugh Matthew K (Exec. VP & CFO) | Buy | 600 | 49.19 | 29,514 |
| 2017-03-07 | Hicks Michael-bryant (General Counsel) | Buy | 290 | 50.35 | 14,601 |
| 2017-02-23 | Fischer Meredith B (Chief Public Affairs Officer) | Buy | 2,000 | 54.34 | 108,676 |
| 2017-02-17 | Watkins Ian J (Chief HR Officer) | Buy | 375 | 54.26 | 20,347 |
| 2017-02-14 | Trudeau Mark (President and CEO) | Buy | 1,000 | 50.47 | 50,466 |
| 2017-02-10 | Romano Steven J. (Exec. VP & Chief Sci. Ofcr) | Buy | 1,000 | 49.68 | 49,680 |
| 2016-05-10 | O'neill Hugh M. (Sr. VP & Pres, ARD) | Buy | 1,653 | 60.99 | 100,816 |
| 2016-05-10 | Harbaugh Matthew K (Sr. VP & CFO) | Buy | 500 | 59.37 | 29,684 |
| 2016-05-06 | Romano Steven J. (Sr. VP & Chief Scientific Ofcr) | Buy | 900 | 56.00 | 50,400 |
| 2016-05-06 | Trudeau Mark (President and CEO) | Buy | 1,000 | 56.02 | 56,021 |
| 2016-03-04 | Lannum Coleman N Iii (Sr.VP, Investor Strategy & IRO) | Buy | 2,600 | 62.63 | 162,838 |
| 2016-02-26 | Fischer Meredith B (Sr. VP, Comm & Public Affairs) | Buy | 1,400 | 69.91 | 97,874 |
| 2016-02-12 | Lannum Coleman N Iii (Sr.VP, Investor Strategy & IRO) | Buy | 600 | 59.66 | 35,796 |
| 2016-02-10 | Lannum Coleman N Iii (Sr.VP, Investor Strategy & IRO) | Buy | 1,300 | 62.58 | 81,354 |
| 2016-02-09 | Harbaugh Matthew K (Sr. VP & CFO) | Buy | 1,300 | 63.00 | 81,900 |
| 2016-02-08 | Lannum Coleman N Iii (Sr.VP, Investor Strategy & IRO) | Buy | 800 | 66.37 | 53,096 |
| 2015-12-22 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 500 | 72.50 | 36,250 |
| 2015-12-16 | Thompson Virgil D (Director) | Sale | 18,000 | 73.62 | 1,325,160 |
| 2015-12-11 | Carlson Terrance L (Interim General Counsel) | Buy | 1,000 | 69.10 | 69,100 |
| 2015-12-04 | Harbaugh Matthew K (Sr. VP & CFO) | Buy | 240 | 73.54 | 17,649 |
| 2015-12-03 | Romano Steven J. (Sr. VP & Chief Scientific Ofcr) | Buy | 700 | 72.60 | 50,819 |
| 2015-12-03 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 500 | 73.17 | 36,585 |
| 2015-12-02 | Phillips Gary M. (Sr. VP, Chief Strategy Officer) | Buy | 1,000 | 72.17 | 72,165 |
| 2015-12-02 | Youngblood Dr Kneeland (Director) | Buy | 675 | 73.30 | 49,477 |
| 2015-12-01 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 200 | 68.35 | 13,669 |
| 2015-11-30 | Trudeau Mark (President & CEO) | Buy | 1,350 | 65.89 | 88,944 |
| 2015-11-27 | O'neill Hugh M. (SVP & Pres, ARD) | Buy | 750 | 66.78 | 50,085 |
| 2015-11-27 | Fischer Meredith B (Sr. VP, Comm & Public Affairs) | Buy | 2,200 | 66.93 | 147,246 |
| 2015-11-27 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 1,200 | 66.86 | 80,226 |
| 2015-11-27 | Carlson Terrance L (Interim General Counsel) | Buy | 1,000 | 66.54 | 66,540 |
| 2015-11-27 | Watkins Ian J (Sr. VP & Chief HR Officer) | Buy | 470 | 66.49 | 31,251 |
| 2015-11-24 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 300 | 65.04 | 19,512 |
| 2015-11-10 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 300 | 57.53 | 17,259 |
| 2015-10-06 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 300 | 63.54 | 19,062 |
| 2015-09-01 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 200 | 84.74 | 16,948 |
| 2015-08-26 | Gulyas Diane H. (Director) | Buy | 850 | 81.26 | 69,071 |
| 2015-08-26 | Watkins Ian J (Sr. VP & Chief HR Officer) | Buy | 610 | 82.44 | 50,285 |
| 2015-08-25 | O'neill Hugh M. (SVP & Pres, ARD) | Buy | 1,197 | 83.52 | 99,973 |
| 2015-08-25 | Trudeau Mark (President & CEO) | Buy | 1,000 | 83.08 | 83,075 |
| 2015-08-25 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 500 | 80.85 | 40,425 |
| 2015-08-21 | Fischer Meredith B (Sr. VP, Comm & Public Affairs) | Buy | 224 | 89.02 | 19,940 |
| 2015-08-21 | Trudeau Mark (President & CEO) | Buy | 2,000 | 88.44 | 176,890 |
| 2015-08-21 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 2,375 | 88.14 | 209,323 |
| 2015-08-07 | Lannum Coleman N Iii (SVP, Investor Strategy & IRO) | Buy | 200 | 98.50 | 19,700 |
| 2015-06-04 | Lannum Coleman N Iii (VP, Investor Relations) | Buy | 1,300 | 126.66 | 164,651 |
| 2015-06-02 | Harbaugh Matthew K (Sr. VP & CFO) | Sale | 3,123 | 129.66 | 404,912 |
| 2015-06-01 | Harbaugh Matthew K (Sr. VP & CFO) | Sale | 18,983 | 128.50 | 2,439,315 |
| 2015-06-01 | Harbaugh Matthew K (Sr. VP & CFO) | Option Ex | 37,617 | 33.10 | 1,245,009 |
| 2015-05-27 | Edwards Peter G (Sr. VP & General Counsel) | Sale | 25,778 | 127.90 | 3,297,006 |
| 2015-05-27 | Edwards Peter G (Sr. VP & General Counsel) | Option Ex | 25,778 | 37.55 | 968,015 |
| 2015-05-22 | Lannum Coleman N Iii (VP, Investor Relations) | Buy | 660 | 127.69 | 84,275 |
| 2015-05-18 | Saltarelli Mario D. (Sr. VP & Chief Science Ofcr.) | Sale | 4,580 | 127.44 | 583,675 |
| 2015-05-18 | Saltarelli Mario D. (Sr. VP & Chief Science Ofcr.) | Option Ex | 3,912 | .00 | 0 |
| 2015-05-13 | Bailey Don M (Director) | Sale | 51,417 | 122.81 | 6,314,264 |
| 2015-05-13 | Bailey Don M (Director) | Option Ex | 51,417 | 26.95 | 1,385,688 |
| 2015-05-11 | Hatten Sandra L (Sr. VP, Quality) | Sale | 2,024 | 122.29 | 247,514 |
| 2015-05-11 | Hatten Sandra L (Sr. VP, Quality) | Option Ex | 2,622 | 37.70 | 98,849 |
| 2015-05-08 | Lannum Coleman N Iii (VP, Investor Relations) | Buy | 340 | 122.52 | 41,656 |
| 2015-04-13 | Bailey Don M (Director) | Sale | 40,000 | 128.24 | 5,129,480 |
| 2015-04-13 | Bailey Don M (Director) | Option Ex | 40,000 | 26.95 | 1,078,000 |
| 2015-03-13 | Bailey Don M (Director) | Sale | 40,000 | 123.67 | 4,946,800 |
| 2015-03-13 | Bailey Don M (Director) | Option Ex | 40,000 | 26.95 | 1,078,000 |
| 2015-02-13 | Bailey Don M (Director) | Sale | 33,891 | 114.53 | 3,881,705 |
| 2015-02-13 | Bailey Don M (Director) | Option Ex | 33,891 | 10.73 | 363,650 |
| 2015-02-02 | Trudeau Mark (President & CEO) | Sale | 11,925 | 106.33 | 1,267,985 |
| 2015-02-02 | Trudeau Mark (President & CEO) | Option Ex | 17,904 | 37.85 | 677,666 |
| 2015-01-09 | Trudeau Mark (President & CEO) | Sale | 15,720 | 102.00 | 1,603,440 |
| 2015-01-09 | Trudeau Mark (President & CEO) | Option Ex | 21,180 | 51.35 | 1,087,593 |
| 2014-12-03 | Harbaugh Matthew K (Sr. VP & CFO) | Buy | 260 | 74.05 | 19,251 |
Insider trading activities including stock purchases, stock sales, and option exercises of NONE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mallinckrodt Plc (symbol NONE, CIK number 1567892) see the Securities and Exchange Commission (SEC) website.